{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:52:26Z","timestamp":1760043146778},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,2,7]],"date-time":"2013-02-07T00:00:00Z","timestamp":1360195200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s11064-013-0982-7","type":"journal-article","created":{"date-parts":[[2013,2,6]],"date-time":"2013-02-06T05:08:24Z","timestamp":1360127304000},"page":"797-806","source":"Crossref","is-referenced-by-count":23,"title":["Effect of \u03b1-Synuclein on Amyloid \u03b2-Induced Toxicity: Relevance to Lewy Body Variant of Alzheimer Disease"],"prefix":"10.1007","volume":"38","author":[{"given":"Rosa","family":"Resende","sequence":"first","affiliation":[]},{"given":"Sueli C. F.","family":"Marques","sequence":"additional","affiliation":[]},{"given":"Elisabete","family":"Ferreiro","sequence":"additional","affiliation":[]},{"given":"Isaura","family":"Sim\u00f5es","sequence":"additional","affiliation":[]},{"given":"Catarina R.","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Cl\u00e1udia M. F.","family":"Pereira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,2,7]]},"reference":[{"key":"982_CR1","doi-asserted-by":"crossref","first-page":"50980","DOI":"10.1074\/jbc.M207825200","volume":"277","author":"C Alves Da Costa","year":"2002","unstructured":"Alves Da Costa C, Paitel E, Vincent B, Checler F (2002) Alpha-synuclein lowers p53-dependent apoptotic response of neuronal cells. Abolishment by 6-hydroxydopamine and implication for Parkinson\u2019s disease. J Biol Chem 277:50980\u201350984","journal-title":"J Biol Chem"},{"key":"982_CR2","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","volume":"30","author":"LK Clinton","year":"2010","unstructured":"Clinton LK, Blurton-Jones M, Myczek K, Trojanowski JQ, LaFerla FM (2010) Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci 30:7281\u20137289","journal-title":"J Neurosci"},{"key":"982_CR3","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1474-9726.2012.00848.x","volume":"11","author":"RO Costa","year":"2012","unstructured":"Costa RO, Lacor PN, Ferreira IL, Resende R, Auberson YP, Klein WL, Oliveira CR, Rego AC, Pereira CM (2012) Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N-methyl-d-aspartate receptor in mature hippocampal cultures treated with amyloid-\u03b2 oligomers. Aging Cell 11:823\u2013833","journal-title":"Aging Cell"},{"key":"982_CR4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1042\/bst0300559","volume":"30","author":"OM el-Agnaf","year":"2002","unstructured":"el-Agnaf OM, Irvine GB (2002) Aggregation and neurotoxicity of alpha-synuclein and related peptides. Biochem Soc Trans 30:559\u2013565","journal-title":"Biochem Soc Trans"},{"key":"982_CR5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neulet.2011.12.005","volume":"507","author":"KL Emmer","year":"2012","unstructured":"Emmer KL, Covy JP, Giasson BI (2012) Studies of protein aggregation in A53T -synuclein transgenic, Tg2576 transgenic, and P246L presenilin-1 knock-in cross bred mice. Neurosci Lett 507:137\u2013142","journal-title":"Neurosci Lett"},{"key":"982_CR6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ceca.2011.11.008","volume":"51","author":"IL Ferreira","year":"2012","unstructured":"Ferreira IL, Bajouco LM, Mota SI, Auberson YP, Oliveira CR, Rego AC (2012) Amyloid beta peptide 1\u201342 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. Cell Calcium 51:95\u2013106","journal-title":"Cell Calcium"},{"key":"982_CR7","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2174\/1389450111007011193","volume":"11","author":"IL Ferreira","year":"2010","unstructured":"Ferreira IL, Resende R, Ferreiro E, Rego AC, Pereira CF (2010) Multiple defects in energy metabolism in Alzheimer\u2019s disease. Curr Drug Targets 11:1193\u20131206","journal-title":"Curr Drug Targets"},{"key":"982_CR8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.nbd.2006.05.011","volume":"23","author":"E Ferreiro","year":"2006","unstructured":"Ferreiro E, Resende R, Costa R, Oliveira CR, Pereira C (2006) An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiol Dis 23:669\u2013678","journal-title":"Neurobiol Dis"},{"key":"982_CR9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1750-3639.2000.tb00269.x","volume":"10","author":"RL Hamilton","year":"2000","unstructured":"Hamilton RL (2000) Lewy bodies in Alzheimer\u2019s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol 10:378\u2013384","journal-title":"Brain Pathol"},{"key":"982_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.40.1.1","volume":"40","author":"L Hansen","year":"1990","unstructured":"Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M et al (1990) The Lewy body variant of Alzheimer\u2019s disease: a clinical and pathologic entity. Neurology 40:1\u20138","journal-title":"Neurology"},{"key":"982_CR11","doi-asserted-by":"crossref","first-page":"11465","DOI":"10.1074\/jbc.M111428200","volume":"277","author":"M Hashimoto","year":"2002","unstructured":"Hashimoto M, Hsu LJ, Rockenstein E, Takenouchi T, Mallory M, Masliah E (2002) alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells. J Biol Chem 277:11465\u201311472","journal-title":"J Biol Chem"},{"key":"982_CR12","volume-title":"A dissection and tissue culture manual of the nervous system","author":"E Hertz","year":"1989","unstructured":"Hertz E, Yua CH, Hertz L, Juurlink BHJ, Schousboe A (1989) Preparation of primary cultures of mouse cortical neurons. In: Shahar A, De Vellis J, Vernadakis A, Haber B (eds) A dissection and tissue culture manual of the nervous system. Alan R Liss, New York"},{"key":"982_CR13","doi-asserted-by":"crossref","first-page":"13092","DOI":"10.1523\/JNEUROSCI.4244-07.2007","volume":"27","author":"H Kaneko","year":"2007","unstructured":"Kaneko H, Kakita A, Kasuga K, Nozaki H, Ishikawa A, Miyashita A, Kuwano R, Ito G, Iwatsubo T, Takahashi H, Nishizawa M, Onodera O, Sisodia SS, Ikeuchi T (2007) Enhanced accumulation of phosphorylated alpha-synuclein and elevated beta-amyloid 42\/40 ratio caused by expression of the presenilin-1 deltaT440 mutant associated with familial Lewy body disease and variant Alzheimer\u2019s disease. J Neurosci 27:13092\u201313097","journal-title":"J Neurosci"},{"key":"982_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.molbrainres.2005.05.022","volume":"139","author":"S Kaul","year":"2005","unstructured":"Kaul S, Anantharam V, Kanthasamy A, Kanthasamy AG (2005) Wild-type alpha-synuclein interacts with pro-apoptotic proteins PKCdelta and BAD to protect dopaminergic neuronal cells against MPP+ -induced apoptotic cell death. Brain Res Mol Brain Res 139:137\u2013152","journal-title":"Brain Res Mol Brain Res"},{"key":"982_CR15","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.neuint.2008.08.004","volume":"53","author":"A Kazmierczak","year":"2008","unstructured":"Kazmierczak A, Strosznajder JB, Adamczyk A (2008) alpha-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells. Neurochem Int 53:263\u2013269","journal-title":"Neurochem Int"},{"key":"982_CR16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00401-005-0027-7","volume":"111","author":"J Klucken","year":"2006","unstructured":"Klucken J, Ingelsson M, Shin Y, Irizarry MC, Hedley-Whyte ET, Frosch M, Growdon J, McLean P, Hyman BT (2006) Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies. Acta Neuropathol 111:101\u2013108","journal-title":"Acta Neuropathol"},{"key":"982_CR17","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/01.WNL.0000165987.89198.65","volume":"64","author":"ML Kraybill","year":"2005","unstructured":"Kraybill ML, Larson EB, Tsuang DW, Teri L, McCormick WC, Bowen JD, Kukull WA, Leverenz JB, Cherrier MM (2005) Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both. Neurology 64:2069\u20132073","journal-title":"Neurology"},{"key":"982_CR18","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1212\/WNL.43.10.1927","volume":"43","author":"PJ Langlais","year":"1993","unstructured":"Langlais PJ, Thal L, Hansen L, Galasko D, Alford M, Masliah E (1993) Neurotransmitters in basal ganglia and cortex of Alzheimer\u2019s disease with and without Lewy bodies. Neurology 43:1927\u20131934","journal-title":"Neurology"},{"key":"982_CR19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2011.07478.x","volume":"120","author":"ME Larson","year":"2012","unstructured":"Larson ME, Lesn\u00e9 SE (2012) Soluble A\u03b2 oligomer production and toxicity. J Neurochem 120:125\u2013139","journal-title":"J Neurochem"},{"key":"982_CR20","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","volume":"26","author":"Y Leng","year":"2006","unstructured":"Leng Y, Chuang DeM (2006) Endogenous \u03b1-syuclein is induced by Valproic Acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity. J Neurosci 26:7502\u20137512","journal-title":"J Neurosci"},{"key":"982_CR21","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","volume":"440","author":"S Lesn\u00e9","year":"2006","unstructured":"Lesn\u00e9 S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440:352\u2013357","journal-title":"Nature"},{"key":"982_CR22","doi-asserted-by":"crossref","first-page":"10960","DOI":"10.1523\/JNEUROSCI.1723-05.2005","volume":"25","author":"J Magran\u00e9","year":"2005","unstructured":"Magran\u00e9 J, Rosen KM, Smith RC, Walsh K, Gouras GK, Querfurth HW (2005) Intraneuronal beta-amyloid expression downregulates the Akt survival pathway and blunts the stress response. J Neurosci 25:10960\u201310969","journal-title":"J Neurosci"},{"issue":"9","key":"982_CR23","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s11064-006-9140-9","volume":"31","author":"PK Mandal","year":"2006","unstructured":"Mandal PK, Pettegrew JW, Masliah E, Hamilton RL, Mandal R (2006) Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer\u2019s and Parkinson\u2019s in dementia with Lewy body disease. Neurochem Res 31(9):1153\u20131162","journal-title":"Neurochem Res"},{"key":"982_CR24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/alzrt109","volume":"4","author":"SE Marsh","year":"2012","unstructured":"Marsh SE, Blurton-Jones M (2012) Examining the mechanisms that link \u03b2-amyloid and \u03b1-synuclein pathologies. Alzheimers Res Ther 4:11","journal-title":"Alzheimers Res Ther"},{"key":"982_CR25","doi-asserted-by":"crossref","first-page":"12245","DOI":"10.1073\/pnas.211412398","volume":"98","author":"E Masliah","year":"2001","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L (2001) beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer\u2019s disease and Parkinson\u2019s disease. Proc Natl Acad Sci USA 98:12245\u201312250","journal-title":"Proc Natl Acad Sci USA"},{"key":"982_CR26","first-page":"317","volume":"2","author":"P Moreira","year":"2000","unstructured":"Moreira P, Pereira C, Santos MS, Oliveira CR (2000) Antiox. Redox. Signal 2:317\u2013325","journal-title":"Signal"},{"key":"982_CR27","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s12640-010-9207-x","volume":"19","author":"RE Musgrove","year":"2011","unstructured":"Musgrove RE, King AE, Dickson TC (2011) Neuroprotective upregulation of endogenous \u03b1-synuclein precedes ubiquitination in cultured dopaminergic neurons. Neurotox Res 19:592\u2013602","journal-title":"Neurotox Res"},{"key":"982_CR28","doi-asserted-by":"crossref","unstructured":"Musgrove RE, King AE, Dickson TC (2012) \u03b1-Synuclein protects neurons from apoptosis downstream of free-radical production through modulation of the MAPK Signalling Pathway. Neurotox Res. doi: 10.1007\/s12640-012-9352-5","DOI":"10.1007\/s12640-012-9352-5"},{"key":"982_CR29","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1212\/WNL.51.2.351","volume":"51","author":"JM Olichney","year":"1998","unstructured":"Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ (1998) Cognitive decline is faster in Lewy body variant than in Alzheimer\u2019s disease. Neurology 51:351\u2013357","journal-title":"Neurology"},{"key":"982_CR30","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1586\/ern.09.107","volume":"9","author":"N Origlia","year":"2009","unstructured":"Origlia N, Arancio O, Domenici L, Yan SS (2009) MAPK, beta-amyloid and synaptic dysfunction: the role of RAGE. Expert Rev Neurother 9:1635\u20131645","journal-title":"Expert Rev Neurother"},{"key":"982_CR31","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awn349","volume":"132","author":"KE Paleologou","year":"2009","unstructured":"Paleologou KE, Kragh CL, Mann DM, Salem SA, Al-Shami R, Allsop D, Hassan AH, Jensen PH, El-Agnaf OM (2009) Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies. Brain 132:1093\u20131101","journal-title":"Brain"},{"key":"982_CR32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.expneurol.2005.10.018","volume":"199","author":"MC Quilty","year":"2006","unstructured":"Quilty MC, King AE, Gai WP, Pountney DL, West AK, Vickers JC, Dickson TC (2006) Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection. Exp Neurol 199:249\u2013256","journal-title":"Exp Neurol"},{"key":"982_CR33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbr.2010.11.017","volume":"217","author":"M Ramin","year":"2011","unstructured":"Ramin M, Azizi P, Motamedi F, Haghparast A, Khodagholi F (2011) Inhibition of JNK phosphorylation reverses memory deficit induced by \u03b2-amyloid (1\u201342) associated with decrease of apoptotic factors. Behav Brain Res 217:424\u2013431","journal-title":"Behav Brain Res"},{"key":"982_CR34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2007.01.071","volume":"1143","author":"R Resende","year":"2007","unstructured":"Resende R, Pereira C, Agostinho P, Vieira AP, Malva JO, Oliveira CR (2007) Susceptibility of hippocampal neurons to A\u03b2 peptide toxicity is associated with perturbation of Ca2+ homeostasis. Brain Res 1143:11\u201321","journal-title":"Brain Res"},{"key":"982_CR35","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neuroscience.2008.06.036","volume":"155","author":"R Resende","year":"2008","unstructured":"Resende R, Ferreiro E, Pereira C, Resende de Oliveira C (2008) Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1\u201342: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 155:725\u2013737","journal-title":"Neuroscience"},{"key":"982_CR36","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jnr.21648","volume":"86","author":"R Resende","year":"2008","unstructured":"Resende R, Ferreiro E, Pereira C, Resende de Oliveira C (2008) ER stress in A\u03b2-induced GSK-3\u03b2 activation and tau phosphorylation. J Neurosci Res 86:2091\u20132099","journal-title":"J Neurosci Res"},{"key":"982_CR37","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1096\/fj.02-0041fje","volume":"16","author":"JH Seo","year":"2002","unstructured":"Seo JH, Rah JC, Choi SH, Shin JK, Min K, Kim HS, Park CH, Kim S, Kim EM, Lee SH, Lee S, Suh SW, Suh YH (2002) Alpha-synuclein regulates neuronal survival via Bcl-2 family expression and PI3\/Akt kinase pathway. FASEB J 16:1826\u20131828","journal-title":"FASEB J"},{"key":"982_CR38","first-page":"367","volume":"152","author":"A Takeda","year":"1998","unstructured":"Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E (1998) Abnormal accumulation of NACP\/alpha-synuclein in neurodegenerative disorders. Am J Pathol 152:367\u2013372","journal-title":"Am J Pathol"},{"key":"982_CR39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0006-8993(99)02207-6","volume":"853","author":"F Yang","year":"2000","unstructured":"Yang F, U\u00e9da K, Chen P, Ashe KH, Cole GM (2000) Plaque-associated alpha-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein. Brain Res 853:381\u2013383","journal-title":"Brain Res"},{"key":"982_CR40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3233\/JAD-2011-110104","volume":"25","author":"G Yin","year":"2011","unstructured":"Yin G, Li LY, Qu M, Luo HB, Wang JZ, Zhou XW (2011) Upregulation of AKT attenuates amyloid-\u03b2-induced cell apoptosis. J Alzheimers Dis 25:337\u2013345","journal-title":"J Alzheimers Dis"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-013-0982-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-013-0982-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-013-0982-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T09:15:25Z","timestamp":1562663725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-013-0982-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["982"],"URL":"https:\/\/doi.org\/10.1007\/s11064-013-0982-7","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,7]]}}}